MPM BioImpact’s Odyssey Therapeutics ODTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.6M Buy
+1,289,091
New +$27.4M 2.13% 22

Other funds holding ODTX

MPM BioImpact's ODTX Position: Q3 2026 in Review

MPM BioImpact opened a new position in Odyssey Therapeutics (ODTX) in Q3 2026: 1,289,091 shares worth $28.6M. The stake represents 2.13% of the portfolio and ranks #22 among its holdings.

72 funds tracked by Wall St. Rank hold ODTX as of Q3 2026.

  • MPM BioImpact held 1,289,091 shares of Odyssey Therapeutics worth $28.6M as of Q3 2026.
  • Odyssey Therapeutics was a new MPM BioImpact position in Q3 2026.
  • Odyssey Therapeutics made up 2.13% of MPM BioImpact's portfolio in Q3 2026, its #22 holding.
  • 72 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q3 2026.

Based on MPM BioImpact's 13F filing for Q3 2026, filed 16 Nov 2026.